Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report. [electronic resource]
Producer: 20181009Description: 593-596 p. digitalISSN:- 1531-4995
- Administration, Intranasal -- adverse effects
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Humans
- Injections -- adverse effects
- Knee
- Male
- Nasal Mucosa
- Osteonecrosis -- chemically induced
- Telangiectasia, Hereditary Hemorrhagic -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.